
Prostate Specific Antigen (PSA) Testing Market
Prostate Specific Antigen (PSA) Testing Market - Global Industry Assessment & Forecast
Segments Covered
By Test Type Preliminary Tests, Confirmatory Tests
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
![]() |
2022 |
![]() |
2023 - 2030 |
![]() |
2017 - 2021 |
![]() |
USD 3.33 Billion |
![]() |
USD 7.74 Billion |
![]() |
11.10% |
![]() |
Asia Pacific |
![]() |
North America |
Customization Offered
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst
Prostate Specific Antigen (PSA) Testing Market Segment Analysis
- Prostate Specific Antigen (PSA) Testing Test Type Outlook (Revenue, USD Million, 2018 - 2030)
- Preliminary Tests
- Confirmatory Tests
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- U.S.
- U.S. Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- U.S. Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Canada
- Canada Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Canada Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Mexico
- Mexico Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Mexico Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
North America Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Europe
-
Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- U. K.
- U.K. Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- U.K. Prostate Specific Antigen (PSA) Testing Market, by Test Type
- France
- France Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- France Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Germany
- Germany Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Germany Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Italy
- Italy Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Italy Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Spain
- Spain Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Spain Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Rest of Europe
- Rest of Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Rest of Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Asia Pacific
-
Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- China
- China Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- China Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Japan
- Japan Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Japan Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Germany
- Germany Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Germany Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
India
- India Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- India Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
South Korea
- South Korea Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- South Korea Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
South East Asia
- South East Asia Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- South East Asia Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Rest of Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Latin America
-
Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Brazil
- Brazil Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Brazil Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Argentina
- Argentina Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Argentina Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Rest of Latin America
- Rest of Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Rest of Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Middle East & Africa
-
Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- GCC Countries
- GCC Countries Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- GCC Countries Prostate Specific Antigen (PSA) Testing Market, by Test Type
- South Africa
- South Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- South Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Rest of Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
- North America

FAQ
Frequently Asked Question
What is the global demand for Prostate Specific Antigen (PSA) Testing in terms of revenue?
-
The global Prostate Specific Antigen (PSA) Testing valued at USD 3.33 Billion in 2022 and is expected to reach USD 7.74 Billion in 2030 growing at a CAGR of 11.10%.
Which are the prominent players in the market?
-
The prominent players in the market are MDx Health (US), Myriad Genetics Inc (US)., Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), OPKO Health Inc. (US), and Genomic Health (US)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 11.10% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Prostate Specific Antigen (PSA) Testing include
- Increased Level of Awareness
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Prostate Specific Antigen (PSA) Testing in 2022.